iRhythm (IRTC) vs Stevanato Group S.p.A. (STVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Stevanato Group S.p.A. (STVN) has outperformed iRhythm (IRTC) over the past year, losing 30.1% versus a loss of 46.7%. Over five years, IRTC leads with a -3.3% price change compared with -30.1% for STVN. Stevanato Group S.p.A. is the larger company by market cap ($4.27 billion vs $3.18 billion), about 1.3 times the size.
On valuation, Stevanato Group S.p.A. trades at a lower forward P/E (21.6x vs 61.6x for iRhythm).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRTC | STVN |
|---|---|---|
| Share price | $94.72 | $15.65 |
| Market cap | $3.18B | $4.27B |
| 1-day change | +0.51% | -1.76% |
| YTD return | -46.62% | -22.22% |
| 1-year return | -46.73% | -30.07% |
| 5-year return | -3.35% | -30.10% |
| P/E ratio (TTM) | — | 26.53 |
| Forward P/E | 61.64 | 21.62 |
| EPS (TTM) | $-1.17 | $0.59 |
| Dividend yield | 0.00% | 0.39% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $747.14M | — |
| Revenue growth (YoY) | +26.24% | — |
| Net income (latest FY) | $-44.55M | — |
| Gross margin | 70.57% | — |
| Operating margin | -7.68% | — |
| Net margin | -5.96% | — |
| 52-week high | $192.47 | $24.01 |
| 52-week low | $82.85 | $12.05 |
| Distance from 52-week high | -50.79% | -34.82% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +61.81% | +24.35% |
| Average volume | 682.68K | 656.22K |
| Shares outstanding | 33.62M | 49.83M |
| Employees | 2,400 | 6,010 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STVN has outperformed IRTC by 16.7 percentage points over the past year.
About iRhythm
IRTC stock →iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Health Care · Medical/Dental Instruments · 2,400 employees
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
IRTC vs STVN FAQ
Which is bigger, iRhythm or Stevanato Group S.p.A.?
Stevanato Group S.p.A. (STVN) is larger, with a market capitalization of $4.27B compared with $3.18B for iRhythm (IRTC).
Which stock has performed better over the past year, IRTC or STVN?
STVN returned -30.07% over the past 12 months, compared with -46.73% for IRTC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, iRhythm or Stevanato Group S.p.A.?
Stevanato Group S.p.A. pays a dividend yielding 0.39%, while iRhythm does not currently pay a regular dividend.
Are iRhythm and Stevanato Group S.p.A. in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.